Case Report: Targeted Therapy with Anlotinib for a Rare Case of Spinal Cord Glioblastoma with FGFR3 Mutation

Primary spinal cord glioblastoma (PSC GBM) is a rare disease with limited treatment options. Here, we describe a case of PSC GBM treated with anlotinib in this report. Molecular characterization confirmed the presence of the MGMT promoter unmethylated, IDH wild type, FGFR3 p.S249C and p53 p.V73fs mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ruiqiong, Wei, Wei, Hou, Huaying, Cong, Ping, Zhou, Yong, Yu, Xiaoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285856/
https://www.ncbi.nlm.nih.gov/pubmed/35847381
http://dx.doi.org/10.2147/OTT.S362185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285856/
https://www.ncbi.nlm.nih.gov/pubmed/35847381
http://dx.doi.org/10.2147/OTT.S362185

Ejemplares similares